Bloomfield Gerald S, Hogan Joseph W, Keter Alfred, Holland Thomas L, Sang Edwin, Kimaiyo Sylvester, Velazquez Eric J
Duke Clinical Research Institute, Duke University, 2400 Pratt Street, Durham, NC 27705, USA.
BMC Infect Dis. 2014 May 22;14:284. doi: 10.1186/1471-2334-14-284.
Mortality among people with human immunodeficiency virus (HIV) infection is increasingly due to non-communicable causes. This has been observed mostly in developed countries and the routine care of HIV infected individuals has now expanded to include attention to cardiovascular risk factors. Cardiovascular risk factors such as high blood pressure are often overlooked among HIV seropositive (+) individuals in sub-Saharan Africa. We aimed to determine the effect of blood pressure on mortality among HIV+ adults in Kenya.
We performed a retrospective analysis of electronic medical records of a large HIV treatment program in western Kenya between 2005 and 2010. All included individuals were HIV+. We excluded participants with AIDS, who were <16 or >80 years old, or had data out of acceptable ranges. Missing data for key covariates was addressed by inverse probability weighting. Primary outcome measures were crude mortality rate and mortality hazard ratio (HR) using Cox proportional hazards models adjusted for potential confounders including HIV stage.
There were 49,475 (74% women) HIV+ individuals who met inclusion and exclusion criteria. Mortality rates for men and women were 3.8 and 1.8/100 person-years, respectively, and highest among those with the lowest blood pressures. Low blood pressure was associated with the highest mortality incidence rate (IR) (systolic <100 mmHg IR 5.2 [4.8-5.7]; diastolic <60 mmHg IR 9.2 [8.3-10.2]). Mortality rate among men with high systolic blood pressure without advanced HIV (3.0, 95% CI: 1.6-5.5) was higher than men with normal systolic blood pressure (1.1, 95% CI: 0.7-1.7). In weighted proportional hazards regression models, men without advanced HIV disease and systolic blood pressure ≥140 mmHg carried a higher mortality risk than normotensive men (HR: 2.39, 95% CI: 0.94-6.08).
Although there has been little attention paid to high blood pressure among HIV+ Africans, we show that blood pressure level among HIV+ patients in Kenya is related to mortality. Low blood pressure carries the highest mortality risk. High systolic blood pressure is associated with mortality among patients whose disease is not advanced. Further investigation is needed into the cause of death for such patients.
人类免疫缺陷病毒(HIV)感染者的死亡越来越多地归因于非传染性病因。这一现象主要在发达国家被观察到,并且现在对HIV感染者的常规护理已扩大到包括关注心血管危险因素。在撒哈拉以南非洲,诸如高血压等心血管危险因素在HIV血清阳性(+)个体中常常被忽视。我们旨在确定血压对肯尼亚HIV阳性成年人死亡率的影响。
我们对2005年至2010年肯尼亚西部一个大型HIV治疗项目的电子病历进行了回顾性分析。所有纳入个体均为HIV阳性。我们排除了患有艾滋病、年龄小于16岁或大于80岁,或数据超出可接受范围的参与者。关键协变量的缺失数据通过逆概率加权法处理。主要结局指标是粗死亡率和死亡率风险比(HR),使用Cox比例风险模型,并对包括HIV分期在内的潜在混杂因素进行了调整。
有49475名(74%为女性)HIV阳性个体符合纳入和排除标准。男性和女性的死亡率分别为3.8和1.8/100人年,且在血压最低的人群中最高。低血压与最高的死亡发病率(IR)相关(收缩压<100 mmHg,IR为5.2 [4.8 - 5.7];舒张压<60 mmHg,IR为9.2 [8.3 - 10.2])。收缩压高且无晚期HIV的男性死亡率(3.0,95%CI:1.6 - 5.5)高于收缩压正常的男性(1.1,95%CI:0.7 - 1.7)。在加权比例风险回归模型中,无晚期HIV疾病且收缩压≥140 mmHg的男性比血压正常男性的死亡风险更高(HR:2.39,95%CI:0.94 - 6.08)。
尽管HIV阳性的非洲人对高血压关注甚少,但我们表明肯尼亚HIV阳性患者的血压水平与死亡率相关。低血压具有最高的死亡风险。收缩压高与疾病未进展患者中的死亡率相关。对此类患者的死因需要进一步调查。